Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer
NCT05976932
·
clinicaltrials.gov ↗
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
pegylated liposomal doxorubicin
Sponsor
Fudan University